Rezo’s scientific co-founders and leaders are:

Nevan Krogan, co-founder and the chief executive officer, is a professor at UCSF, director of QBI and a senior investigator at Gladstone Institutes.
Kevan Shokat is a co-founder and a professor at UCSF as well as an investigator of HHMI.
George Scangos is a co-founder and chair of the board of directors of Rezo. Scangos is the president, chief executive officer and a member of the board at Vir Biotechnology and was previously the chief executive officer at Biogen.
Nobert Bischofberger is a co-founder and member of the board of directors. Bischofberger is the president and chief executive officer of Kronos Bio and was previously the executive vice president of research & development and chief scientific officer at Gilead Sciences.
Natalia Jura, a co-founder, is a professor of Cellular and Molecular Pharmacology, an investigator at the Cardiovascular Research Institute, and an associate director of QBI at UCSF.

Rezo’s Platform Could ‘Fundamentally Shift’ Drug Discovery

More from New Science